TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0170
0.00 (0.00%)
At close: Dec 17, 2025
TrivarX Market Cap
TrivarX has a market cap or net worth of 12.17 million as of December 17, 2025. Its market cap has increased by 66.44% in one year.
Market Cap
12.17M
Enterprise Value
11.09M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 12.17M, an increase of 5.21%. That is a compound annual growth rate of 0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 12.17M | 63.64% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | 10.78M | 8.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.50B |
| Pro Medicus | 23.62B |
| Cochlear | 17.30B |
| Sonic Healthcare | 11.36B |
| Ramsay Health Care | 8.13B |
| Ansell | 5.12B |
| Telix Pharmaceuticals | 4.46B |
| Mesoblast | 3.55B |